Bayer Schering Pharma Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 5,085.5 | 6,304.1 | 1,332.5 |
| Net Investing Cash Flow | (4,353.9) | 4,689.5 | (1,190.0) |
| Net Financing Cash Flow | (1,230.5) | (11,377.8) | (269.1) |
| Net Change in Cash | (499.0) | (384.2) | (126.7) |
| Depreciation & Amortization | -- | -- | -- |
| Capital Expenditures | -- | (2,737.7) | -- |
| Cash Dividends Paid | -- | (1,137.8) | -- |
© 2009 Morningstar, Inc. Financial Data provided by
